These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16515302)

  • 21. Adjuvant therapy of colon cancer.
    Sun W; Haller DG
    Semin Oncol; 2005 Feb; 32(1):95-102. PubMed ID: 15726511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
    Motomura S
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
    [No Abstract]   [Full Text] [Related]  

  • 23. [Present status and prospect of irinotecan application in adjuvant therapy for colorectal cancer].
    Zhou ZT; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):553-4. PubMed ID: 17147128
    [No Abstract]   [Full Text] [Related]  

  • 24. Irinotecan and 5-FU/ leucovorin in metastatic colorectal cancer: balancing efficacy, toxicity, and logistics.
    Hwang JJ
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):26-34. PubMed ID: 15685831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moving beyond fluorouracil for colorectal cancer.
    Mayer RJ
    N Engl J Med; 2000 Sep; 343(13):963-4. PubMed ID: 11006373
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvant therapy of colon cancer: a review.
    Hobday TJ; Erlichman C
    Clin Colorectal Cancer; 2002 Feb; 1(4):230-6. PubMed ID: 12450421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the role of angiogenesis as a chemotherapeutic target.
    Chu E
    Clin Colorectal Cancer; 2003 Aug; 3(2):74-5. PubMed ID: 12952560
    [No Abstract]   [Full Text] [Related]  

  • 28. Turning point for colorectal cancer clinical trials.
    Meropol NJ
    J Clin Oncol; 2006 Jul; 24(21):3322-4. PubMed ID: 16849744
    [No Abstract]   [Full Text] [Related]  

  • 29. Considering Efficacy and Cost, Where Does Ramucirumab Fit in the Management of Metastatic Colorectal Cancer?
    Goldstein DA; El-Rayes BF
    Oncologist; 2015 Sep; 20(9):981-2. PubMed ID: 26265225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
    Allegra C; George T; Yothers G
    J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adjuvant therapy for colon cancer].
    Moiseenko VM; Orlova RV
    Vopr Onkol; 1998; 44(6):741-5. PubMed ID: 10087982
    [No Abstract]   [Full Text] [Related]  

  • 32. Folinic acid (CF)/5-fluorouracil (FUra) combinations in advanced gastrointestinal carcinomas.
    Wilke H; Schmoll HJ; Preusser P; Fink U; Stahl M; Schöber C; Link H; Freund M; Hanauske A; Meyer HJ
    Adv Exp Med Biol; 1988; 244():233-43. PubMed ID: 3073658
    [No Abstract]   [Full Text] [Related]  

  • 33. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic chemotherapy for metastatic colorectal cancer: reasons to combine.
    Calvo E
    Clin Colorectal Cancer; 2002 Nov; 2(3):170-2. PubMed ID: 12482333
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis.
    Masi G; Vasile E; Loupakis F; Cupini S; Fornaro L; Baldi G; Salvatore L; Cremolini C; Stasi I; Brunetti I; Fabbri MA; Puglisi M; Trenta P; Granetto C; Chiara S; Fioretto L; Allegrini G; Crinò L; Andreuccetti M; Falcone A
    J Natl Cancer Inst; 2011 Jan; 103(1):21-30. PubMed ID: 21123833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy.
    Bruckner HW; Spigelman M
    Mt Sinai J Med; 1988 Oct; 55(5):390-4. PubMed ID: 3265179
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
    Kalofonos HP; Kardamakis D; Bamias A; Skarlos D; Papakostas P; Bafaloukos D; Sakantamis A; Pavlidis N; Fountzilas G
    Anticancer Res; 2003; 23(2C):1687-91. PubMed ID: 12820441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer.
    Douillard JY;
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):51-5. PubMed ID: 11200150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoadjuvant chemotherapy of irinotecan, 5-fluorouracil and leucovorin in patients with advanced rectal cancer. Report of two cases.
    Hasegawa H; Watanabe M; Baba H; Yoshinare K; Mukai M; Kubota T; Kitajima M
    Hepatogastroenterology; 2002; 49(46):891-3. PubMed ID: 12143234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of intra-arterial high-dose leucovorin and 5-FU including combination chemotherapy].
    Mitsuhata N; Matsuda T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3287-90. PubMed ID: 3490831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.